The Impact of Non-dopaminergic Medication on Quality of Life in Parkinson’s Disease

Nicol G.M. Oonk*, Kris L.L. Movig, Job van der Palen, Henk-Willem Nijmeijer, Mirjam E. van Kesteren, Lucille D.A. Dorresteijn

*Corresponding author for this work

    Research output: Contribution to journal › Article › Academic › peer-review

    2 Citations (Scopus)
    62 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'The Impact of Non-dopaminergic Medication on Quality of Life in Parkinson’s Disease'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science